Inventor

MITCHELL SCOTT A

US61 patents

⚠️ This page may combine multiple inventors who share the name “MITCHELL SCOTT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MITCHELL SCOTT A

GILEAD SCIENCES INC

Syk inhibitors

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

Substituted 6-azabenzimidazole compounds

Substituted pyrrolidines as SYK inhibitors

Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine

Substituted 6-azabenzimidazole compounds

Substituted 6-azabenzimidazole compounds

Syk inhibitors

Syk inhibitors

Substituted 6-azabenzimidazole compounds

Tank-binding kinase inhibitor compounds

Substituted eneoxindoles and uses thereof

GILEAD CONNECTICUT INC

6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma

Imidazopyrizine syk inhibitors

6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor

6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitor

N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors

Imidazopyrazine Syk inhibitors

Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

Imidazopyridines Syk inhibitors

Pyridone and aza-pyridone compounds and methods of use

CGI PHARMACEUTICALS INC

Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton&#39;s tyrosine kinase by such compounds

Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity

Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton&#39;s tyrosine kinase by such compounds

Certain substituted pyrazinones

Certain substituted amides, method of making, and method of use thereof

6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof

Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity

Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity

Certain substituted amides, method of making, and method of use thereof

Certain amino-substituted monocycles as kinase modulators

MITCHELL SCOTT A

6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

Imidazopyrazine Syk inhibitors

Imidazopyrazine Syk inhibitors

Imidazopyrazine SYK inhibitors

BLOMGREN PETER A

Imidazopyridines Syk inhibitors

Certain substituted amides, method of making, and method of use thereof

Certain substituted amides, method of making, and method of use thereof

SANDIA CORP

Connectivity-based, all-hexahedral mesh generation method and apparatus

Method for generating a mesh representation of a region characterized by a trunk and a branch thereon

KRONOS BIO INC

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine

Imidazopyridines Syk inhibitors

CELLULAR GENOMICS INC

Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof

BARBOSA ANTONIO J M

Pyridone and aza-pyridone compounds and methods of use

NEUROGEN CORP

Substituted tetrahydroisoquinolines as C5a receptor modulators

NURIX THERAPEUTICS INC

Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof

Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds

Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds